Paper I — 2024 December (Supplementary) (2019 Scheme) — Qxvi
2 min read
Paper I
2024 December (Supplementary) (2019 Scheme) · 100 marks · 180 min
Question
Assertion (A): Nitroglycerine is administered by sublingual route in acute attack of angina
pectoris.
Reason (R): Nitroglycerine has high oral bioavailability
a) Both A and R are true, and R is the correct explanation of A
b) Both A and R are true, and R is not the correct explanation of A
c) A is true, but R is false
d) A is false, but R is true
Qxvi1 marksMCQs
Answer
Correct answer: c) A is true, but R is false
A is true — nitroglycerine is given sublingually for acute anginal attacks, for rapid onset. R is false: nitroglycerine actually has very low oral bioavailability, due to extensive first-pass hepatic metabolism — this is precisely why the sublingual route is used, to bypass first-pass metabolism entirely, not because oral bioavailability is high.